Patents by Inventor Frank C. Schroeder

Frank C. Schroeder has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250179108
    Abstract: The present invention relates to methods of treating immune disorders and/or inflammation using certain modulator compounds. In one embodiment, the present invention provides a method of treating an immune and inflammatory disorders disorder by administering a composition comprising a therapeutically effective dosage of an ascaroside compound, or a mixture of ascaroside compounds, or a mixture containing at least one ascaroside.
    Type: Application
    Filed: December 11, 2024
    Publication date: June 5, 2025
    Inventors: Andrea Choe, Paul W. Sternberg, Frank C. Schroeder, Stephan H. Van Reuss
  • Publication number: 20250161241
    Abstract: The invention relates to cysteamides, therapeutic compositions containing such cysteamides and methods of using the same.
    Type: Application
    Filed: March 1, 2023
    Publication date: May 22, 2025
    Inventors: Frank C. Schroeder, David Artis, Mohammad Arifuzzaman, Christopher N. Parkhurst, Tae Hyung Won
  • Patent number: 12180246
    Abstract: The present invention relates to methods of treating immune disorders and/or inflammation using certain modulator compounds. In one embodiment, the present invention provides a method of treating an immune and inflammatory disorders disorder by administering a composition comprising a therapeutically effective dosage of an ascaroside compound, or a mixture of ascaroside compounds, or a mixture containing at least one ascaroside.
    Type: Grant
    Filed: June 12, 2023
    Date of Patent: December 31, 2024
    Assignees: California Institute of Technology, Boyce Thompson Institute for Plant Research
    Inventors: Andrea Choe, Paul W. Sternberg, Frank C. Schroeder, Stephan H. Von Reuss
  • Publication number: 20240358735
    Abstract: The invention relates to modular glucosides (MOGLs), therapeutic compositions containing such MOGLs and methods of using the same.
    Type: Application
    Filed: August 26, 2022
    Publication date: October 31, 2024
    Inventors: Frank C. SCHROEDER, Chester J. J. WROBEL, Brian J. CURTIS, Jingfang YU, Pedro RODRIGUES, Arnaud TAUFFENBERGER, Bingsen ZHANG, Aleksandra SKIRYCZ, Venkatesh Periyakavanam THIRUMALAIKUMAR
  • Publication number: 20240018177
    Abstract: The present invention relates to methods of treating immune disorders and/or inflammation using certain modulator compounds. In one embodiment, the present invention provides a method of treating an immune and inflammatory disorders disorder by administering a composition comprising a therapeutically effective dosage of an ascaroside compound, or a mixture of ascaroside compounds, or a mixture containing at least one ascaroside.
    Type: Application
    Filed: June 12, 2023
    Publication date: January 18, 2024
    Inventors: Andrea Choe, Paul W. Sternberg, Frank C. Schroeder, Stephan H. von Reuss
  • Patent number: 11673908
    Abstract: The present invention relates to methods of treating immune disorders and/or inflammation using certain modulator compounds. In one embodiment, the present invention provides a method of treating an immune and inflammatory disorders disorder by administering a composition comprising a therapeutically effective dosage of an ascaroside compound, or a mixture of ascaroside compounds, or a mixture containing at least one ascaroside.
    Type: Grant
    Filed: August 1, 2022
    Date of Patent: June 13, 2023
    Assignees: California Institute of Technology, Boyce Thompson Institute for Plant Research
    Inventors: Andrea Choe, Paul W. Sternberg, Frank C. Schroeder, Stephan H. Von Reuss
  • Publication number: 20230026686
    Abstract: A method of preventing or treating eosinophilic esophagitis (EoE) comprising administering a composition comprising ascr #7 is described.
    Type: Application
    Filed: September 9, 2022
    Publication date: January 26, 2023
    Inventors: Andrea CHOE, Paul W. Sternberg, Frank C. Schroeder
  • Publication number: 20230024046
    Abstract: The present invention relates to methods of treating immune disorders and/or inflammation using certain modulator compounds. In one embodiment, the present invention provides a method of treating an immune and inflammatory disorders disorder by administering a composition comprising a therapeutically effective dosage of an ascaroside compound, or a mixture of ascaroside compounds, or a mixture containing at least one ascaroside.
    Type: Application
    Filed: August 1, 2022
    Publication date: January 26, 2023
    Inventors: Andrea Choe, Paul W. Sternberg, Frank C. Schroeder, Stephan H. Von Reuss
  • Patent number: 11464810
    Abstract: A method of preventing or treating eosinophilic esophagitis (EoE) comprising administering a composition comprising ascr#7 is described.
    Type: Grant
    Filed: August 25, 2017
    Date of Patent: October 11, 2022
    Assignees: California Institute of Technology, Boyce Thompson Institute for Plant Research
    Inventors: Andrea Choe, Paul W. Sternberg, Frank C. Schroeder
  • Publication number: 20220016182
    Abstract: The present invention relates to the use of ascr#7 for preventing or treating IL-6 and/or IL-1?-mediated diseases.
    Type: Application
    Filed: July 30, 2021
    Publication date: January 20, 2022
    Inventors: Andrea Choe, Paul W. Sternberg, Frank C, Schroeder
  • Patent number: 11077151
    Abstract: The present invention relates to the use of ascr #7 for preventing or treating IL-6 and/or IL-1?-mediated diseases.
    Type: Grant
    Filed: August 25, 2017
    Date of Patent: August 3, 2021
    Assignees: California Institute of Technology, Boyce Thompson Institute for Plant Research
    Inventors: Andrea Choe, Paul W. Sternberg, Frank C. Schroeder
  • Publication number: 20200262856
    Abstract: The present invention relates to methods of treating immune disorders and/or inflammation using certain modulator compounds. In one embodiment, the present invention provides a method of treating an immune and inflammatory disorders disorder by administering a composition comprising a therapeutically effective dosage of an ascaroside compound, or a mixture of ascaroside compounds, or a mixture containing at least one ascaroside.
    Type: Application
    Filed: November 15, 2019
    Publication date: August 20, 2020
    Inventors: Andrea Choe, Paul W. Sternberg, Frank C. Schroeder, Stephan H. Von Reuss
  • Patent number: 10479813
    Abstract: The present invention relates to methods of treating immune disorders and/or inflammation using certain modulator compounds. In one embodiment, the present invention provides a method of treating an immune and inflammatory disorders disorder by administering a composition comprising a therapeutically effective dosage of an ascaroside compound, or a mixture of ascaroside compounds, or a mixture containing at least one ascaroside.
    Type: Grant
    Filed: January 18, 2019
    Date of Patent: November 19, 2019
    Assignees: California Institute of Technology, Boyce Thompson Institute for Plant Research
    Inventors: Andrea Choe, Paul W. Sternberg, Frank C. Schroeder, Stephan H. Von Reuss
  • Publication number: 20190192578
    Abstract: A method of preventing or treating eosinophilic esophagitis (EoE) comprising administering a composition comprising ascr#7 is described.
    Type: Application
    Filed: August 25, 2017
    Publication date: June 27, 2019
    Inventors: Andrea Choe, Paul W. Sternberg, Frank C. Schroeder
  • Publication number: 20190175663
    Abstract: The present invention relates to the use of ascr#7 for preventing or treating IL-6 and/or IL-1?-mediated diseases.
    Type: Application
    Filed: August 25, 2017
    Publication date: June 13, 2019
    Inventors: Andrea Choe, Paul W. Sternberg, Frank C. Schroeder
  • Publication number: 20190153014
    Abstract: The present invention relates to methods of treating immune disorders and/or inflammation using certain modulator compounds. In one embodiment, the present invention provides a method of treating an immune and inflammatory disorders disorder by administering a composition comprising a therapeutically effective dosage of an ascaroside compound, or a mixture of ascaroside compounds, or a mixture containing at least one ascaroside.
    Type: Application
    Filed: January 18, 2019
    Publication date: May 23, 2019
    Inventors: Andrea Choe, Paul W. Sternberg, Frank C. Schroeder, Stephan H. Von Reuss
  • Patent number: 10183963
    Abstract: The present invention relates to methods of treating immune disorders and/or inflammation using certain modulator compounds. In one embodiment, the present invention provides a method of treating an immune and inflammatory disorders disorder by administering a composition comprising a therapeutically effective dosage of an ascaroside compound, or a mixture of ascaroside compounds, or a mixture containing at least one ascaroside.
    Type: Grant
    Filed: December 6, 2017
    Date of Patent: January 22, 2019
    Assignees: California Institute of Technology, Boyce Thompson Institute for Plant Research
    Inventors: Andrea Choe, Paul W. Sternberg, Frank C. Schroeder, Stephan H. Von Reuss
  • Publication number: 20180162893
    Abstract: The present invention relates to methods of treating immune disorders and/or inflammation using certain modulator compounds. In one embodiment, the present invention provides a method of treating an immune and inflammatory disorders disorder by administering a composition comprising a therapeutically effective dosage of an ascaroside compound, or a mixture of ascaroside compounds, or a mixture containing at least one ascaroside.
    Type: Application
    Filed: December 6, 2017
    Publication date: June 14, 2018
    Inventors: Andrea Choe, Paul W. Stemberg, Frank C. Schroeder, Stephen H. Von Reuss
  • Publication number: 20180045715
    Abstract: Compositions and methods for identifying agents which 1) mimic salicyclic acid binding to human, animal and plant high mobility group box proteins or 2) alter activities of these HMGBs by binding in or around their salicyclic acid-binding sites and agents so identified are disclosed.
    Type: Application
    Filed: February 12, 2016
    Publication date: February 15, 2018
    Inventors: Daniel F. Klessig, Sang-Wook Park, Hyong Woo Choi, Frank C. Schroeder, Gaetano T. Montelione, Keith Hamilton, Swapna Gurla, Fei Song, Marco E. Bianchi
  • Patent number: 9868754
    Abstract: The present invention relates to methods of treating immune disorders and/or inflammation using certain modulator compounds. In one embodiment, the present invention provides a method of treating an immune and inflammatory disorders disorder by administering a composition comprising a therapeutically effective dosage of an ascaroside compound, or a mixture of ascaroside compounds, or a mixture containing at least one ascaroside.
    Type: Grant
    Filed: August 8, 2012
    Date of Patent: January 16, 2018
    Assignees: California Institute of Technology, Boyce Thompson Institute for Plant Research
    Inventors: Andrea Choe, Paul W. Sternberg, Frank C. Schroeder, Stephan H. Von Reuss